Citation: Dg. Pfister et al., A new intensified therapeutic regimen for advanced head and neck squamous cell carcinomas: Where does it fit among available treatment options?, CANCER INV, 19(2), 2001, pp. 217-218
Authors:
Wolden, SL
Zelefsky, MJ
Kraus, DH
Rosenzweig, KE
Chong, LM
Shaha, AR
Zhang, H
Harrison, LB
Shah, JP
Pfister, DG
Citation: Sl. Wolden et al., Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma, J CL ONCOL, 19(4), 2001, pp. 1105-1110
Authors:
Wolden, SL
Zelefsky, MJ
Hunt, MA
Rosenzweig, KE
Chong, LM
Kraus, DH
Pfister, DG
Leibel, SA
Citation: Sl. Wolden et al., Failure of a 3D conformal boost to improve radiotherapy for nasopharyngealcarcinoma, INT J RAD O, 49(5), 2001, pp. 1229-1234
Citation: Sl. Wolden et al., Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer, INT J RAD O, 46(4), 2000, pp. 859-864
Authors:
Wolden, SL
Anderson, JR
Crist, WM
Breneman, JC
Wharam, MD
Wiener, ES
Qualman, SJ
Donaldson, SS
Citation: Sl. Wolden et al., Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma studies I to III, J CL ONCOL, 17(11), 1999, pp. 3468-3475